results from vital: survival benefit of birtamimab in mayo stage iv al amyloidosis
Published 1 year ago • 146 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:35
vital results for birtamimab in al amyloidosis
-
2:49
survival benefit of birtamimab in treating al amyloidosis
-
1:10
exploring the next era of treating al amyloidosis: role of birtamimab
-
2:48
an overview of trials in progress in al amyloidosis: highlights from isa 2024
-
2:20
new prognostic markers in al amyloidosis
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:54
results of the morbida trial: 18f-pet for the detection of cardiac involvement in al amyloidosis
-
1:08
challenges in understanding and diagnosing attr amyloidosis
-
1:42
first results of the apollo trial: atra-ato versus soc in high-risk acute promyelocytic leukemia
-
2:41
an overview of the latest advances in hematology
-
1:08
top-flor: treatment of newly-diagnosed fl with golcadomide, rituximab /- nivolumab
-
1:38
feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
-
1:15
an insight into response criteria for waldenström’s macroglobulinemia
-
0:56
real-world survival in patients with mixed phenotype attr-cm treated with tafamidis
-
0:58
belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
-
3:05
forum results: tbi vs myeloablative chemo-based conditioning pre-allosct in high-risk pediatric all
-
3:23
updated safety and efficacy results of abbv-383, a novel bsab, in patients with r/r multiple myeloma
-
1:05
alterations to the bone marrow microenvironment in patients with al amyloidosis